All News

A pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.

The study’s co-primary endpoint of overall survival was not formally tested due to DFS not being reached.

In diabetic rats, investigators found a decrease in urine biomarkers and expression of proteins that play a part in renin-angiotensin system (RAS).

SNB-101 is the first nanoparticle anticancer drug that was developed exceedingly insoluble SN-38 into polymer nanoparticles.

Antihemophilic factor (recombinant) Fc-VWF-XTEN fusion protein-ehtl was initally approved in February 2023 for adults and children with hemophilia A for prophylaxis and on-demand treatment to control bleeding.

The data were previously presented at the Multilateral Initiative on Malaria 8th Pan-African Malaria Conference and have been submitted for regulatory review.

Study investigators also found that dietary modifications were not associated in improving risks of certain chronic diseases and cancers.

Complementary and integrative health has been divided into 5 subcategories, including alternative whole medical systems and mind-body interventions.

FDA approves groundbreaking gene therapies for sickle cell disease, revolutionizing treatment.

The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.

Addressing the long-term effects of RSV in older adults is crucial for public health and patient care.

A provisional determination is also provided for the 40 mg/0.4 mL strength due to remaining interchangeability designation for another biosimilar to Humira.

This is the first approval of an EB virus-related mRNA therapeutic cancer vaccine and is a landmark achievement in future research on cancer treatment.

Strategies for intervention design focused on opportunities for both patients and providers by way of medication labeling, specific prescription instructions, prescribing prompts, and educational services.

Investigators noted that the conditional overall survival also had clinically meaningful improvements compared with sorafenib for advanced renal cell carcinoma.

On this episode, Amie Stephens, Emilee Kennelly, and Max Baire, discuss social determinants of health and how they can impact patient outcomes and medication adherence.

As pharmacists continue to step into additional roles, culturally competent care becomes an even more essential part of their practices.

These developments highlight the dynamic landscape of health care innovation and the collaborative efforts driving progress in disease management and treatment.

The Rika system uses an individualized nomogram to help determine the plasma collection volume that is needed for each individual donor.

A clinical pharmacist discusses his work in the mental health space while stressing the importance of advocating for and checking in with one another’s emotional well-being.

With worsening news from accounting, where does community pharmacy go from here?

The results also showed that the PET scans could show damage to the individual’s brains, which was correlated with disability and fatigue.

This study is the first to preliminarily show that a community pharmacist intervention can produce a positive effect on reducing SABA reliance and improvement of ICS adherence in patients with asthma.

The ability to selectively silence or downregulate specific genes has opened new avenues for treating a myriad of diseases.

Community-based pharmacists performed mightily at a cost-efficient scale and safety record that rivaled any in the history of health professions.

This issue of Pharmacy Practice in Focus: Health Systems provides an overview of the considerations for the implementation of CRISPR and Cas9 cell-based gene therapies in sickle cell disease.

Tune into this episode of “Public Health Matters” to hear Dr. Kate Gainer’s journey in state pharmacy association and how advocacy and legislative initiatives can benefit pharmacists.